AxoGen Owners | StatInvestor

Health Care & Life Sciences » Medical Equipment & Supplies | AxoGen Inc.

AxoGen Inc. | Ownership

Companies that own AxoGen Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

BlackRock Fund Advisors

2,256,764

5.89%

329,472

0.01%

06/30/2018

The Vanguard Group, Inc.

1,443,362

3.77%

150,136

06/30/2018

Opaleye Management, Inc.

1,440,000

3.76%

-275,000

15.92%

06/30/2018

Marshall Wace LLP

1,168,953

3.05%

1,168,953

0.64%

06/30/2018

FIAM LLC

1,037,585

2.71%

-425,050

0.09%

06/30/2018

ArrowMark Colorado Holdings LLC

1,011,402

2.64%

-271,994

0.4%

06/30/2018

Renaissance Technologies LLC

998,300

2.61%

110,500

0.05%

06/30/2018

AllianceBernstein LP

972,220

2.54%

909,470

0.02%

06/30/2018

Eagle Asset Management, Inc.

906,339

2.37%

638,019

0.18%

06/30/2018

Columbia Wanger Asset Management LLC

820,797

2.14%

-231,500

0.3%

06/30/2018

About AxoGen

View Profile

Address	13631 Progress Boulevard Alachua Florida 32615 United States
Employees	-
Website	http://www.axogeninc.com
Updated	07/08/2019
AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provide products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator.